Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats

被引:22
作者
Imoto, Keisuke [1 ]
Okada, Muneyoshi [1 ]
Yamawaki, Hideyuki [1 ]
机构
[1] Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Higashi 23 Bancho 35-1, Towada, Aomori 0348628, Japan
关键词
extracellular matrix; matricellular proteins; monocrotaline; pulmonary hypertension; right ventricular hypertrophy; INDUCED CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; ANGIOTENSIN-II; HEART-DISEASE; TENASCIN-C; FIBROSIS; FAILURE; OSTEOPONTIN; METABOLISM; PERIOSTIN;
D O I
10.1292/jvms.17-0053
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Matricellular proteins, a non-structural extracellular matrix (ECM) component, bind to and modulate various molecules including growth factor, cytokine, protease, other ECM components and cell membrane receptors. While most matricellular proteins are hardly expressed in normal adult tissue, they are re-expressed in heart tissue during cardiac diseases. The present study aimed to clarify the mRNA expression profile of matricellular proteins [secreted protein acidic and rich in cysteine: SPARC, hevin, thrombospondin (TSP)-1, -2 and -4, CCN1 and 5, tenascin (Tn) C and N, periostin and osteopontin (OPN)] in hypertrophied right ventricle (RV) of monocrotaline (MCT)-induced pulmonary hypertensive rats. Male Wistar rats were intraperitoneally treated with MCT or saline. Two or three weeks after MCT treatment, echocardiography was performed, and mRNA expression of matricellular proteins was measured by real-time polymerase chain reaction. MCT (2 weeks) induced pulmonary hypertension, RV dysfunction and hypertrophy, which were all worsened 3 weeks after MCT treatment. Expression of mRNA for SPARC, hevin, TnC, TSP-1, -2 and -4, CCN1 and 5, periostin and OPN but not TnN was significantly upregulated in RV of MCT (2 weeks)-treated rats. Expression of mRNA for TSP-4, CCN1 and 5 and periostin was continuously increased in RV of MCT (3 weeks)-treated rats. The present study for the first time revealed the mRNA expression profile for matricellular proteins in RV of MCT-treated rats for 2 or 3 weeks, which will be helpful to clarify the relationship for matricellular proteins and pathogenesis of MCT-induced RV hypertrophy.
引用
收藏
页码:1096 / 1102
页数:7
相关论文
共 34 条
  • [1] A thrombospondin-1 antagonist of transforming growth factor-β activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II
    Belmadani, Souad
    Bernal, Juan
    Wei, Chih-Chang
    Pallero, Manuel A.
    Dell'Italia, Louis
    Murphy-Ullrich, Joanne E.
    Berecek, Kathleen H.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03) : 777 - 789
  • [2] ECM remodeling in hypertensive heart disease
    Berk, Bradford C.
    Fujiwara, Keigi
    Lehoux, Stephanie
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) : 568 - 575
  • [3] SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength
    Bradshaw, AD
    Puolakkainen, P
    Dasgupta, J
    Davidson, JM
    Wight, TN
    Sage, EH
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (06) : 949 - 955
  • [4] Pressure Overload-Induced Alterations in Fibrillar Collagen Content and Myocardial Diastolic Function Role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in Post-Synthetic Procollagen Processing
    Bradshaw, Amy D.
    Baicu, Catalin F.
    Rentz, Tyler J.
    Van Laer, An O.
    Boggs, Janet
    Lacy, John M.
    Zile, Michael R.
    [J]. CIRCULATION, 2009, 119 (02) : 269 - U119
  • [5] Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart
    Collins, AR
    Schnee, J
    Wang, W
    Kim, S
    Fishbein, MC
    Bruemmer, D
    Law, RE
    Nicholas, S
    Ross, RS
    Hsueh, WA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (09) : 1698 - 1705
  • [6] MATRICELLULAR PROTEINS IN CARDIAC ADAPTATION AND DISEASE
    Frangogiannis, Nikolaos G.
    [J]. PHYSIOLOGICAL REVIEWS, 2012, 92 (02) : 635 - 688
  • [7] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [8] Gosavi Sucheta, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P50
  • [9] Pressure Overload-induced Right Ventricular Failure is Associated with Re-expression of Myocardial Tenascin-C and Elevated Plasma Tenascin-C Levels
    Hessel, Marleen
    Steendijk, Paul
    den Adel, Brigit
    Schutte, Cindy
    van der Laarse, Arnoud
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2009, 24 (3-4) : 201 - 210
  • [10] Regulation of proangiogenic factor CCN1 in cardiac muscle - Impact of ischemia, pressure overload, and neurohumoral activation
    Hilfiker-Kleiner, D
    Kaminski, K
    Kaminska, A
    Fuchs, M
    Klein, G
    Podewski, E
    Grote, K
    Kiian, I
    Wollert, KC
    Hilfiker, A
    Drexler, H
    [J]. CIRCULATION, 2004, 109 (18) : 2227 - 2233